Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Cancer Res. 2014 May 1;74(13):3591–3602. doi: 10.1158/0008-5472.CAN-13-2149

Table 1.

MTBP mRNA is overexpressed in many human cancers

Cancer Type Fold Change p-value Reference
Breast ductal carcinoma
(N=78, C=639)
1.87 – 2.66 1.3E-02 to 3E-23 (4042)
Cervical carcinoma
(N=8, C=20)
2.12 1.8E-06 (43)
Colorectal carcinoma
(N=97, C=273)
1.60 – 3.71 4.6E-04 to 1.2E-19 (44, 45)
Gastric adenocarcinoma
(N=50, C=91)
1.43 – 2.25 3.1E-04 to 1.9E-10 (46)
Glioblastoma
(N=23, C=81)
2.25 4.8E-04 (47)
Lung adenocarcinoma
(N=65, C=45)
1.54 2E-07 (48)
Lung large cellcarcinoma
(N=65, C=19)
2.28 1.9E-06 (48)
Lung squamous cell carcinoma
(N=65, C=27)
1.62 1.9E-08 (48)
Prostate carcinoma
(N=8, C=13)
1.65 9.1E-04 (49)
Squamous cell carcinoma
(N=4, C=11)
1.97 9.5E-04 (50)

MTBP mRNA expression data in cancer (C) compared to normal (N) tissue from Oncomine; p-values determined by log-rank test

HHS Vulnerability Disclosure